Is insulin atherogenic?
Stout, R.W.
Mount Sinai Journal of Medicine new York 49(3): 223-226
1982
ISSN/ISBN: 0027-2507 PMID: 6750367 Document Number: 191703
Document emailed within 1 workday
Related Documents
Ogunro, P.S.; Ologunagba, P.O. 2012: Plasma level of atherogenic and anti-atherogenic factors among palm wine drinkers of rural southwest Nigeria African Journal of Medicine and Medical Sciences 41(4): 337-347Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452
Klöppel, G.; Freytag, G.; Graesslin, D. 1973: Preparation of monomer insulin components and insulin-like contaminants from crystalline insulin by isoelectric focusing technique Acta Endocrinologica. Supplementum 173: 58
Chang, T.C.; Wang, L.M.; Cheng, C.Y.; Kuo, H.F.; Liu, P.C.; Ho, L.T. 1990: The action of gliclazide on insulin secretion and insulin sensitivity in non-obese non-insulin dependent diabetic patients Zhonghua Yi Xue Za Zhi 46(2): 79-85
De Meijer, P.H.; Lutterman, J.A. 1990: Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin Netherlands Journal of Medicine 36(1-2): 4-12
Fernández Landó, L.; Massari, F.; Oviedo, A.; Jiang, H. 2012: Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes Medicina 72(3): 235-242
Hildebrandt, P. 1991: Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors Danish Medical Bulletin 38(4): 337-346
Beck-Nielsen, H.; Henriksen, J.E.; Alford, F.; Hother-Nielson, O. 1996: In vivo glucose metabolism, insulin secretion and, insulin action in Europids with non-insulin-dependent diabetes mellitus (NIDDM) and their first-degree relatives Diabetic Medicine: a Journal of the British Diabetic Association 13(9 Suppl 6: S78-S84
Lepore, G.; Dodesini, A.R.; Nosari, I.; Trevisan, R. 2004: Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study Diabetes Nutrition and Metabolism 17(2): 84-89
De Meyts, P. 1994: Insulin receptors and mechanism of action of insulin and of insulin-like growth factors Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 149(3-4): 181-190; Discussion: 190-194
Imachi, H.; Murao, K. 2012: Insulin, glucagon, insulin autoantibody (IAA), insulin receptor antibody Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 442-445
Mohan, V.; Das, A.K.; Joshi, S.R. 2015: Insulin Degludec/Insulin Aspart: a Novel Co-formulation for Insulin Intensification Journal of the Association of Physicians of India 63(5 Suppl): 6-7
Okada, Y. 2012: New information of oral insulin, nasal insulin and inhaled insulin Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 678-681
Yanagisawa, K. 1992: A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal Hokkaido Journal of Medical Science 67(1): 81-88
Jungmann, E. 1997: From human insulin to designer insulin. Why insulin analogs? Fortschritte der Medizin 115(12): 40-41
Zemel, M.B. 1995: Insulin resistance vs. hyperinsulinemia in hypertension: insulin regulation of Ca2+ transport and Ca(2+)-regulation of insulin sensitivity Journal of Nutrition 125(6 Suppl): 1738s-1743s
De Gennes, J.L.; Turpin, G.; Truffert, J.; Labrousse, B. 1972: Corrective therapy of atherogenic hyperlipemia Acta Cardiologica 1972: Suppl 15: 115-113
Mel'nikova, N.V.; Zvenigorodskaia, L.A.; Khomeriki, S.G. 2008: Hepatic changes in patients with atherogenic dyslipidemia Eksperimental'naia i Klinicheskaia Gastroenterologiia 5: 111-119
Mertz, D.P. 1984: Lp(a): a little known, independent atherogenic risk factor Die Medizinische Welt 35(3): 92-95
Zozulińska, D. 2006: Atherogenic dyslipidaemia in type 2 diabetes Kardiologia Polska 64(10 Suppl 6: S567-S571